Nancy Pelosi’s husband buys millions worth of Nvidia stock ahead of chip-manufacturing bill vote
- Thread starter Maxxam
- Start date
There's websites such as these that show what she and other politicians are buying:
Nancy Pelosi Tracker
A fund that follows Rep. Pelosi's publicly visible equity exposure. Automatically rebalanced as her public accounts change.
The problem is that they have 45 days to disclose any trades or purchases they made so a lot can happen to a stock within those days.
Insider trading is common place in Congress.
We need joint R&D, this is what Intel and other chip companies really need. The $50 billion could be given out now as a down payment; however, a long term strategy would be this.
This is all I can say on the matter for now, otherwise, I will be watching my idea going into another product without getting paid.
This is all I can say on the matter for now, otherwise, I will be watching my idea going into another product without getting paid.
Your crazy ass be saying some shit from time to time. This is a REAL problem. They have a true monopoly on microprocessorsAfter observing what you guys are doing in the U.S., I have a few comments. These chip companies own shares in ASML, and have created the illusion of competition on the retail side, but profit handsomely with their joint venture ownership of this company. Instead of giving huge tax subsidies, they need the DOJ to bust up this clever monopoly schemes.
It would be similar to Apple, Google, Motorola, Samsung owning some joint asset together pushing some inflated price equally down to consumer, than this joint privately held company raking in the profits. We will see competition on the retail side.
This is their new hustle scam, so be on the alert!
Building some huge factory with few jobs, all the robots, Gigapress, and lithographic machines that costs half a billion dollars will be made somewhere else. If it is a foreign brand, they will build their factory here and 'import' their machines from back home, creating a virtual shell factory. Meanwhile the U.S. citizen will be on the hook for huge tax breaks and subsidies.
"Did you really believe I did not see it, youngling"
You're insane again.. whew. Ty I thought I was the one going crazy for a second. If the network actually operated like that then no place would be a safe haven. There will always be knock-on/contagion effect in loop systems.
My gut feeling based on my experience, this is the new model for producing advanced manufacturing in the U.S. such as vaccine and chipmaking. You force the government to front up the money in the event of damages. No telling what these corrupt politicians are capable of doing whether handing your R&D off to another country for a payoff or another company. They have no morals or sense of business ethics.
They basically trickle produce chips for cars, to make its impact known to the public. Than you ask for money, don't rely on patent system to protect your interest.
The old way of doing things was sinking billions of dollars into R&D than expecting the government to protect your interest with patents. I have proven beyond a reasonable doubt that the government gets involve with commercial interest for insider information or to pass on to their corporate donors using the NSA or some other entity.
They basically trickle produce chips for cars, to make its impact known to the public. Than you ask for money, don't rely on patent system to protect your interest.
The old way of doing things was sinking billions of dollars into R&D than expecting the government to protect your interest with patents. I have proven beyond a reasonable doubt that the government gets involve with commercial interest for insider information or to pass on to their corporate donors using the NSA or some other entity.
Last edited:
Bold part below explains why Pelosi husband went all in on Nvidia stock
Biden poised for big wins in Congress
After a long stretch when his legislative program stalled, Biden and the Democrats appear ready to notch a string of victories
By Yasmeen Abutaleb
and
Mike DeBonis
Updated July 26, 2022 at 3:40 p.m. EDT|Published July 25, 2022 at 8:01 p.m. EDT
President Biden at a virtual meeting with CEOs and labor leaders Monday to discuss a bill boosting the manufacturing of semiconductors in the United States. (Demetrius Freeman/The Washington Post)
The first major prescription drug legislation in nearly 20 years. More than $50 billion to subsidize computer chip manufacturing and research. A bill that would enshrine protection for same-sex marriage.
After a turbulent stretch in which much of President Biden’s legislative agenda seemed to be foundering, the president and his party may be on the cusp of significant wins in Congress that the White House hopes will provide at least a modest political boost.
Biden poised for big wins in Congress
After a long stretch when his legislative program stalled, Biden and the Democrats appear ready to notch a string of victories
By Yasmeen Abutaleb
and
Mike DeBonis
Updated July 26, 2022 at 3:40 p.m. EDT|Published July 25, 2022 at 8:01 p.m. EDT
President Biden at a virtual meeting with CEOs and labor leaders Monday to discuss a bill boosting the manufacturing of semiconductors in the United States. (Demetrius Freeman/The Washington Post)
The first major prescription drug legislation in nearly 20 years. More than $50 billion to subsidize computer chip manufacturing and research. A bill that would enshrine protection for same-sex marriage.
After a turbulent stretch in which much of President Biden’s legislative agenda seemed to be foundering, the president and his party may be on the cusp of significant wins in Congress that the White House hopes will provide at least a modest political boost.
Most politically resonant is a bill to let Medicare negotiate drug prices, a hugely popular idea that Democrats have been pursuing for more than 20 years. It would let Medicare negotiate prices for 10 drugs in 2026 and 10 more in 2029; forbid drug companies from raising prices faster than inflation; and cap Medicare recipients’ out-of-pocket costs for prescription drugs at $2,000 a year.
Even before that — possibly within days — Congress is likely to pass a bill providing $52 billion for companies to build, modernize or expand factories that produce semiconductors, the brains that power all modern electronics, to bolster the American economy and counter China’s influence. “We’re close, so let’s get it done,” Biden said of the bill on Monday. “So much depends on it.”
Democrats hope these measures earn a bigger political payoff than, say, Biden’s infrastructure law, which seemed to make little impression on voters.
“Democrats now seem to be hitting a stride where they’re about to rattle off three meaningful victories in a short amount of time, and for really the first time have an open field to politically gain from that,” said Kurt Bardella, a former Republican who now consults for Democrats. “On the health-care bill, this is stuff everybody generally understands. This is not a complex, nuanced policy situation where you may not feel the benefit for 5 to 10 years.”
The legislative wins come at a precarious time for the president and congressional Democrats, who have struggled to overcome poor public views of the economy due to persistent inflation as well as Biden’s low approval ratings. While several recent polls have shown congressional Democrats slightly improving their standing against Republicans, they remain at serious risk of losing their House and Senate majorities in November.
The upcoming bills could still be disrupted by some last-minute glitches, not least a coronavirus outbreak in the Senate that has temporarily sidelined such key figures as Sens. Joe Manchin III (D-W.Va.) and Lisa Murkowski (R-Alaska). And the semiconductor bill is a whittled-down version of a broader bill intended to boost U.S. competitiveness against China that some Republicans opposed.
The Medicare drug bill is especially notable, despite only covering some medications, because it marks the most significant drug-pricing legislation since 2003. Polls show that health care, and the cost of prescription drugs in particular, consistently ranks as a top voter concern. The bill would also provide a two-year extension of enhanced Affordable Care Act subsidies that would prevent health insurance premiums from rising significantly for many people.
Rep. Spanberger joins Biden to talk prescription drugs
The prescription drug legislation has enormous bipartisan support, with more than 90 percent of Americans saying in a March 2022 Kaiser Family Foundation poll that letting the government negotiate with drug companies to get a lower price on Medicare prescription drugs should be an “important priority” or a “top priority” for Congress.
The semiconductor bill would also provide tens of billions of dollars for the National Science Foundation and regional tech start-ups.
Semiconductors are vital to an array of technological products, and China has been investing billions to make itself the leader in the field. While strategists said the bill would be harder for Democrats to message given its impact will be felt over years, not months, the legislation could eventually help address rising car prices that have in part been fueled by a chip shortage.
Semiconductor shortage hammers automakers
Biden, who is still in isolation after testing positive for the coronavirus last week, appeared during a virtual event on Monday with CEOs and labor leaders to urge Congress to pass the bill. “China is moving ahead of us in producing these sophisticated chips,” Biden said. “It’s no wonder China is watching this bill so carefully, and actively lobbying U.S. businesses against this bill.”
Meanwhile, a bill that Democrats offered to codify same-sex and interracial marriage recently attracted 47 Republican votes in the House, surprising leaders of both parties and igniting a push by Senate Democrats to pass the legislation in their chamber as well. The goal is protect these couples’ right to marry from being overturned by the Supreme Court, which has signaled it may want to revisit such issues.
The House approved on July 19 a bill that would federally protect same-sex marriages, but it’s unclear if the legislation can pass the Senate. (Video: Hadley Green/The Washington Post)
Biden advisers said the bills, if they all pass, will help the president draw a contrast between Democrats’ agenda and what they portray as an increasingly extreme GOP that is out of step with most Americans on issues ranging from abortion to same-sex marriage to gun control. But those advisers said they are not yet assuming the bills will become law, and caution there is work ahead.
“Middle-class families need breathing room, and the deficit reduction [the health-care bill] accomplishes that and will also help fight inflation," said Andrew Bates, White House deputy press secretary.
On the chips and same-sex marriage bills, he added, "Passing a landmark China competitiveness bill that will create manufacturing jobs across the country and standing up for the fundamental right of every American to marry who they love would be profound bipartisan wins for the county.”
Still, the various pieces of legislation could help boost Biden’s public standing, which has suffered as he has faced one crisis after another over the last year and a half. Biden took office as the coronavirus pandemic was raging and killing thousands of people a day, and he saw much of his coronavirus agenda struck down by the Supreme Court.
Since then, he has dealt with record inflation, a baby formula shortage, numerous mass shootings, increasingly transmissible coronavirus variants, Russia’s invasion of Ukraine and a highly conservative Supreme Court that overturned the constitutional right to abortion, curbed the power of the Environmental Protection Agency, and rolled back states’ ability to implement gun-control measures.
The legislative victories that Biden has secured so far — a coronavirus relief package, a $1.2 trillion infrastructure bill that he signed in November and a modest gun-control package that broke a 30-year logjam on the issue — have quickly been overtaken by events, or have been dismissed by many liberals as too small to meet the moment. The gun legislation, for instance, came amid a series of mass shootings, including a July 4 massacre at a parade in Highland Park, Ill., and as the Supreme Court struck down a New York law limiting residents’ ability to carry a weapon.
Both the bipartisan semiconductor bill and the Democratic prescription drug bill would represent major, politically significant achievements, but each represents a retreat from far bigger, more sweeping proposals. And Biden’s push for voting rights and police reform legislation collapsed, while a much-prized climate measure is on life support.
As a result, many Democratic lawmakers, activists and rank-and-file voters see the pending bills as a bitterly disappointing half-loaf rather than a triumph.
“This is a very big deal, and if Democrats had tried to just do this, it would be looked at as an enormous achievement,” Phil Schiliro, who was the head of legislative affairs for President Barack Obama, said of the health-care bill. “Because it was tied in with other things that aren’t going to be included, a lot of people look at what’s not in it, versus what this achieves and what it does for people.”
Many Democrats said privately that the White House was too quick to set soaring expectations when the party took over the presidency and Congress in 2021, given their historically narrow majorities. The prescription drug bill, for example, could be all that survives of a once-sweeping $2 trillion domestic policy package known as Build Back Better, which some Democrats compared to the New Deal and the Great Society in its size and scope.
Democrats scrambled last summer to set the fiscal parameters for Build Back Better, passing a budget that set the stage for $3.5 trillion in new spending that would include affordable child care and free prekindergarten, subsidize at-home care for the elderly and the disabled, create the largest investment in clean energy and climate programs in American history, expand access to community college, and deliver monthly tax credit payments to the vast majority of American families with school-age children.
But that agenda may have been better suited to a commanding majority than a Senate split 50-50 between the parties with Vice President Harris casting tiebreaking votes. Manchin and Sen. Kyrsten Sinema (D-Ariz.) regularly threatened to defect; Sinema privately opposed many of the tax increases financing the package, and Manchin had a laundry list of fiscal and policy concerns, showing consistent skepticism of the climate provisions and insisting that the bill refrain from financial “gimmicks.”
Those warnings only increased in late 2021 as inflation rose. Shortly before Christmas last year, Manchin publicly announced he could no longer support Build Back Better as a massive policy program. Efforts to rebuild a deal faltered again this month when Manchin backed away from supporting any climate or tax provisions, leaving only the health-care pieces.
The semiconductor bill went through a similar, if less dramatic, shrinking act. The U.S. Innovation and Competition Act had its roots in a bipartisan effort to wholly remake the federal government’s approach to supporting science and technology research.
With more than $100 billion in funding attached, as well as a passel of trade provisions, the bill passed the Senate in June 2021 with the support of 19 Republicans. But a companion House bill moved much more slowly as Democrats there sought to leverage their own priorities, such as a renewal of federal assistance to workers disadvantaged by foreign trade. An effort to mediate between the two chambers ended in an impasse last month, leading to the stripped-down bill now set for Senate passage this week.
The White House hopes a legislative flurry will rewrite the storyline of Biden’s legislative record.
The current push has taken on an added urgency because operatives in both parties expect Democrats to lose control of the House and possibly the Senate in November, meaning the window for Biden’s agenda is rapidly closing.
Party strategists say that if Biden and Democrats capitalize on the passage of the bills and reinforce the message to voters that they are passing policies that help lower their costs, Democrats could help shift the narrative that they have little to show for their unified control of government.
“These legislative victories would be very significant because they address voters’ top concerns, which is inflation and the cost of prescription drugs,” said Ben LaBolt, a Democratic strategist. “The best thing the president can do — the most effective thing he can do politically — is to make progress on what Americans are saying is a top priority for them.”
Even before that — possibly within days — Congress is likely to pass a bill providing $52 billion for companies to build, modernize or expand factories that produce semiconductors, the brains that power all modern electronics, to bolster the American economy and counter China’s influence. “We’re close, so let’s get it done,” Biden said of the bill on Monday. “So much depends on it.”
Democrats hope these measures earn a bigger political payoff than, say, Biden’s infrastructure law, which seemed to make little impression on voters.
“Democrats now seem to be hitting a stride where they’re about to rattle off three meaningful victories in a short amount of time, and for really the first time have an open field to politically gain from that,” said Kurt Bardella, a former Republican who now consults for Democrats. “On the health-care bill, this is stuff everybody generally understands. This is not a complex, nuanced policy situation where you may not feel the benefit for 5 to 10 years.”
The legislative wins come at a precarious time for the president and congressional Democrats, who have struggled to overcome poor public views of the economy due to persistent inflation as well as Biden’s low approval ratings. While several recent polls have shown congressional Democrats slightly improving their standing against Republicans, they remain at serious risk of losing their House and Senate majorities in November.
The upcoming bills could still be disrupted by some last-minute glitches, not least a coronavirus outbreak in the Senate that has temporarily sidelined such key figures as Sens. Joe Manchin III (D-W.Va.) and Lisa Murkowski (R-Alaska). And the semiconductor bill is a whittled-down version of a broader bill intended to boost U.S. competitiveness against China that some Republicans opposed.
The Medicare drug bill is especially notable, despite only covering some medications, because it marks the most significant drug-pricing legislation since 2003. Polls show that health care, and the cost of prescription drugs in particular, consistently ranks as a top voter concern. The bill would also provide a two-year extension of enhanced Affordable Care Act subsidies that would prevent health insurance premiums from rising significantly for many people.
Rep. Spanberger joins Biden to talk prescription drugs
The prescription drug legislation has enormous bipartisan support, with more than 90 percent of Americans saying in a March 2022 Kaiser Family Foundation poll that letting the government negotiate with drug companies to get a lower price on Medicare prescription drugs should be an “important priority” or a “top priority” for Congress.
The semiconductor bill would also provide tens of billions of dollars for the National Science Foundation and regional tech start-ups.
Semiconductors are vital to an array of technological products, and China has been investing billions to make itself the leader in the field. While strategists said the bill would be harder for Democrats to message given its impact will be felt over years, not months, the legislation could eventually help address rising car prices that have in part been fueled by a chip shortage.
Semiconductor shortage hammers automakers
Biden, who is still in isolation after testing positive for the coronavirus last week, appeared during a virtual event on Monday with CEOs and labor leaders to urge Congress to pass the bill. “China is moving ahead of us in producing these sophisticated chips,” Biden said. “It’s no wonder China is watching this bill so carefully, and actively lobbying U.S. businesses against this bill.”
Meanwhile, a bill that Democrats offered to codify same-sex and interracial marriage recently attracted 47 Republican votes in the House, surprising leaders of both parties and igniting a push by Senate Democrats to pass the legislation in their chamber as well. The goal is protect these couples’ right to marry from being overturned by the Supreme Court, which has signaled it may want to revisit such issues.
The House approved on July 19 a bill that would federally protect same-sex marriages, but it’s unclear if the legislation can pass the Senate. (Video: Hadley Green/The Washington Post)
Biden advisers said the bills, if they all pass, will help the president draw a contrast between Democrats’ agenda and what they portray as an increasingly extreme GOP that is out of step with most Americans on issues ranging from abortion to same-sex marriage to gun control. But those advisers said they are not yet assuming the bills will become law, and caution there is work ahead.
“Middle-class families need breathing room, and the deficit reduction [the health-care bill] accomplishes that and will also help fight inflation," said Andrew Bates, White House deputy press secretary.
On the chips and same-sex marriage bills, he added, "Passing a landmark China competitiveness bill that will create manufacturing jobs across the country and standing up for the fundamental right of every American to marry who they love would be profound bipartisan wins for the county.”
Still, the various pieces of legislation could help boost Biden’s public standing, which has suffered as he has faced one crisis after another over the last year and a half. Biden took office as the coronavirus pandemic was raging and killing thousands of people a day, and he saw much of his coronavirus agenda struck down by the Supreme Court.
Since then, he has dealt with record inflation, a baby formula shortage, numerous mass shootings, increasingly transmissible coronavirus variants, Russia’s invasion of Ukraine and a highly conservative Supreme Court that overturned the constitutional right to abortion, curbed the power of the Environmental Protection Agency, and rolled back states’ ability to implement gun-control measures.
The legislative victories that Biden has secured so far — a coronavirus relief package, a $1.2 trillion infrastructure bill that he signed in November and a modest gun-control package that broke a 30-year logjam on the issue — have quickly been overtaken by events, or have been dismissed by many liberals as too small to meet the moment. The gun legislation, for instance, came amid a series of mass shootings, including a July 4 massacre at a parade in Highland Park, Ill., and as the Supreme Court struck down a New York law limiting residents’ ability to carry a weapon.
Both the bipartisan semiconductor bill and the Democratic prescription drug bill would represent major, politically significant achievements, but each represents a retreat from far bigger, more sweeping proposals. And Biden’s push for voting rights and police reform legislation collapsed, while a much-prized climate measure is on life support.
As a result, many Democratic lawmakers, activists and rank-and-file voters see the pending bills as a bitterly disappointing half-loaf rather than a triumph.
“This is a very big deal, and if Democrats had tried to just do this, it would be looked at as an enormous achievement,” Phil Schiliro, who was the head of legislative affairs for President Barack Obama, said of the health-care bill. “Because it was tied in with other things that aren’t going to be included, a lot of people look at what’s not in it, versus what this achieves and what it does for people.”
Many Democrats said privately that the White House was too quick to set soaring expectations when the party took over the presidency and Congress in 2021, given their historically narrow majorities. The prescription drug bill, for example, could be all that survives of a once-sweeping $2 trillion domestic policy package known as Build Back Better, which some Democrats compared to the New Deal and the Great Society in its size and scope.
Democrats scrambled last summer to set the fiscal parameters for Build Back Better, passing a budget that set the stage for $3.5 trillion in new spending that would include affordable child care and free prekindergarten, subsidize at-home care for the elderly and the disabled, create the largest investment in clean energy and climate programs in American history, expand access to community college, and deliver monthly tax credit payments to the vast majority of American families with school-age children.
But that agenda may have been better suited to a commanding majority than a Senate split 50-50 between the parties with Vice President Harris casting tiebreaking votes. Manchin and Sen. Kyrsten Sinema (D-Ariz.) regularly threatened to defect; Sinema privately opposed many of the tax increases financing the package, and Manchin had a laundry list of fiscal and policy concerns, showing consistent skepticism of the climate provisions and insisting that the bill refrain from financial “gimmicks.”
Those warnings only increased in late 2021 as inflation rose. Shortly before Christmas last year, Manchin publicly announced he could no longer support Build Back Better as a massive policy program. Efforts to rebuild a deal faltered again this month when Manchin backed away from supporting any climate or tax provisions, leaving only the health-care pieces.
The semiconductor bill went through a similar, if less dramatic, shrinking act. The U.S. Innovation and Competition Act had its roots in a bipartisan effort to wholly remake the federal government’s approach to supporting science and technology research.
With more than $100 billion in funding attached, as well as a passel of trade provisions, the bill passed the Senate in June 2021 with the support of 19 Republicans. But a companion House bill moved much more slowly as Democrats there sought to leverage their own priorities, such as a renewal of federal assistance to workers disadvantaged by foreign trade. An effort to mediate between the two chambers ended in an impasse last month, leading to the stripped-down bill now set for Senate passage this week.
The White House hopes a legislative flurry will rewrite the storyline of Biden’s legislative record.
The current push has taken on an added urgency because operatives in both parties expect Democrats to lose control of the House and possibly the Senate in November, meaning the window for Biden’s agenda is rapidly closing.
Party strategists say that if Biden and Democrats capitalize on the passage of the bills and reinforce the message to voters that they are passing policies that help lower their costs, Democrats could help shift the narrative that they have little to show for their unified control of government.
“These legislative victories would be very significant because they address voters’ top concerns, which is inflation and the cost of prescription drugs,” said Ben LaBolt, a Democratic strategist. “The best thing the president can do — the most effective thing he can do politically — is to make progress on what Americans are saying is a top priority for them.”
Yup they talked about this on Market Mondays Earn Your Leisure....
All public knowledge
Senate Stock Watcher - See What Senators are Trading
Updated Daily - See the stock trades US Senators are making as they are reported. Get notifications when new reports are uploaded. Get insight now!
senatestockwatcher.com
The U.S. is a horrible place to do business, they would have to pay similar sums of money to me. Don't rely on some bureaucratic corrupt process (Patents) that will need massive amount of money to grease the wheels
The chip companies have inverted what politicians do, which is slow walk something you need for campaign donations and bribes. Here they slow walked chip production impacting car production and other important products.
The chip companies have inverted what politicians do, which is slow walk something you need for campaign donations and bribes. Here they slow walked chip production impacting car production and other important products.
Semiconductor production is similar to printing newspapers, very little labor input into making millions of newspaper a day, that are automated by machines. The machine that prints the newspapers is made in Europe that costs alot of money. This bill does not address this issue at all.
@xfactor called these shell factories which they are to us.
Any corrupt politician touting this as bringing manufacturing home, creating jobs is scamming you. Somebody linked this bill to Bobby Rush which is no surprise coming out of Chicago. They are the epicenter of promoting contract manufactured products made overseas and touting opportunities with getting a college degree that don't exist. It would be like me telling the Latino community that they need to give up construction and farm work by pursuing a college degree competing with Asians that dominate jobs at Google, Microsoft, and Amazon by leveraging market access back home.
I am ranting about this because this is an example of the rudimentary games and corruption that forced me to leave the U.S. due to limited business opportunites/crime.
Fortunately, EV tax credit legislation, that I had a hand in creating is a step in the right direction.
@xfactor called these shell factories which they are to us.
Any corrupt politician touting this as bringing manufacturing home, creating jobs is scamming you. Somebody linked this bill to Bobby Rush which is no surprise coming out of Chicago. They are the epicenter of promoting contract manufactured products made overseas and touting opportunities with getting a college degree that don't exist. It would be like me telling the Latino community that they need to give up construction and farm work by pursuing a college degree competing with Asians that dominate jobs at Google, Microsoft, and Amazon by leveraging market access back home.
I am ranting about this because this is an example of the rudimentary games and corruption that forced me to leave the U.S. due to limited business opportunites/crime.
Fortunately, EV tax credit legislation, that I had a hand in creating is a step in the right direction.
Off to you and the other BGOL coons to beat yourself into a coma in this thread, circle jerking each other
Tech & Politics: US orders Nvidia and AMD to stop selling AI chips to China
https://www.cnn.com/2022/09/01/tech/us-nvidia-amd-chips-china-sales-block-intl-hnk/index.html US orders Nvidia and AMD to stop selling AI chips to China https://www.cnn.com/profiles/michelle-toh-profile By Michelle Toh, CNN Business Updated 12:28 AM ET, Thu September 1, 2022 She brought AMD...
www.bgol.us
Dang